DEXCOM INC — Director's Dealing 2017

Jun 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2017-06-01

Reporting Person: FOLETTA MARK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-01	Common Stock	A	4952	$0.0010	Acquired	20595	Direct

Footnotes

F1: Share units are restricted and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.

F2: Included in this number are 7,240 unvested restricted stock units, 4,952 of which were granted on June 1, 2017 and shall vest on June 1, 2018 and 2,288 of which were granted on November 17, 2014 and shall vest through November 17, 2017.